Edison Pharmaceuticals Lands $50,000,135 New Funding

  • Feed Type
  • Date
    3/28/2014
  • Company Name
    Edison Pharmaceuticals
  • Mailing Address
    350 N. Bernardo Ave Mountain View, CA 94043 USA
  • Company Description
    Edison’s business is the development of drugs to treat diseases that impair energy metabolism. Energy impairment diseases can be classified on the basis of whether they are inherited or acquired, and furthermore on the location of the defect. Edison is initially focusing on inherited diseases of the mitochondria- nature’s biological energy substation.
  • Website
    http://www.edisonpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $50,000,135
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy